GM-CSF therapy does not improve treadmill walking time in patients with...
Joseph Poole, M.D., Ph.D., of the Emory University School of Medicine, Atlanta, and colleagues studied whether therapy with granulocyte-macrophage colony stimulating factor (GM-CSF), an agent that...
View ArticleAtheroNova completes active treatment portion of Phase 1 clinical trial with...
AtheroNova Inc., a biotech company focused on the research and development of compounds to safely regress atherosclerotic plaque and improve lipid profiles in humans, today announces achievement of a...
View ArticleResearchers awarded $25 million NIH grant to study critical limb ischemia...
A team of researchers from Brigham and Women's Hospital, Boston Medical Center and Massachusetts General Hospital has been awarded $25 million by the National Institutes of Health to conduct a...
View ArticleBunker Vein and Imaging Center starts second location in Round Rock
Bunker Vein and Imaging Center is proud to announce its second location, which opened this month in Round Rock, Texas. Dr. Stephen Bunker and his medical team have been treating patients with varicose...
View ArticleProteon's PRT-201 gets orphan drug designation for prevention of...
Proteon Therapeutics, Inc., a privately held biopharmaceutical company developing novel, first-in-class pharmaceuticals to address the critical medical needs of patients with kidney and vascular...
View ArticleStudy finds that Mediterranean diet may also prevent peripheral artery disease
A multicenter study that previously reported a reduction in heart attack and stroke with a Mediterranean diet supplemented with extra-virgin olive oil or with nuts now also reports a lower risk of...
View ArticleStroke hospitalization and death rates associated with weather changes
Stroke hospitalization and death rates may rise and fall with changes in environmental temperature and dew point, according to research presented at the American Stroke Association's International...
View ArticleCardioCell announces new clinical trials using allogeneic stem-cell therapy...
CardioCell LLC announces two new clinical trials using its allogeneic stem-cell therapy to treat subjects with acute myocardial infarction (AMI), a problem facing more than 1.26 million Americans...
View ArticleGenetic study reveals 11 new genetic signals are associated with blood...
A large international study analyzing genes in tens of thousands of individuals has discovered 11 new genetic signals associated with blood pressure levels. Ten of those signals are in or very near...
View ArticleMarital status affects risk of heart disease, survey shows
Analysis of surveys of more than 3.5 million American men and women, administered at some 20,000 health centers across the country - believed to be the largest analysis of its kind ever performed -...
View ArticleMarriage linked to lower risk of cardiovascular disease
Marriage is criticized for many things — justly and unjustly — but not heart disease, according to findings of a recent study conducted by researchers at NYU Langone Medical Center.
View ArticleHeart problems less likely for spouses than for single people
People who are married have lower rates of several cardiovascular diseases compared with those who are single, divorced or widowed, according to research to be presented at the American College of...
View ArticleCardioCell receives IND approval for Phase IIa clinical study of itMSC...
CardioCell LLC has just received the FDA's investigational new drug (IND) approval for a United States-based, Phase IIa clinical study using its allogeneic stem-cell therapy to treat subjects with...
View ArticleMarijuana may cause heart complications in young people
Marijuana smoking may increase the risk of serious and even fatal heart problems among young or middle-aged users, according to a new French study.
View ArticleStudy shows room for improvement in medical management of women with PAD
Women face greater limits on their lifestyle and have more severe symptoms as a result of peripheral artery disease (PAD), but minimally invasive procedures used to unclog arteries are just as...
View ArticleCordis launches SABER Catheter for treatment of patients with Peripheral...
Cordis Corporation announced today the launch of its SABER PTA Dilatation Catheter ("SABER Catheter") for the treatment of patients with Peripheral Arterial Disease (PAD).
View ArticleNew study finds link between lower socioeconomic status and higher rates of...
Previous research has established a link between lower socioeconomic status and an increased risk of cardiovascular disease. In a new study led by Brigham and Women's Hospital, researchers have found...
View ArticleCardioNova initiates Phase 1b clinical trial with AtheroNova's AHRO-001
AtheroNova Inc., a biotech company focused on the research and development of compounds to safely regress atherosclerotic plaque and improve lipid profiles in humans, today announces that its partner,...
View ArticleCalcium buildup in coronary arteries of chronic kidney disease patients...
Calcium buildup in the coronary arteries of chronic kidney disease patients may be a strong indicator of heart disease risk, according to a new study in the Journal of the American Society of...
View ArticleJanssen, Bayer announce expansion of EXPLORER global cardiovascular research...
Janssen Research & Development, LLC and its development partner, Bayer HealthCare, announced today the expansion of the EXPLORER global cardiovascular research program for XARELTO (rivaroxaban) to...
View Article
